Anemia is a frequent comorbidity of chronic kidney disease (CKD) and is associated with a
considerable burden because of decreased patient health-related quality of life and …

Background The anaemia seen in chronic kidney disease (CKD) may be exacerbated by
iron deficiency. Iron can be provided through different routes, with advantages and …

Since the inception of the Canadian Cardiovascular Society heart failure (HF) guidelines in
2006, much has changed in the care for patients with HF. Over the past decade, the HF …

Background Reductions in health-related quality of life (HRQoL) in patients with chronic
kidney disease (CKD) are thought to be exacerbated by the low hemoglobin (Hb) levels that …

Chronic kidney disease (CKD) affects approximately 10% of the worldwide population;
anaemia is a frequent complication. Inadequate erythropoietin production and absolute or …

Introduction: In the last three decades, health systems have continued to pay increasing
attention to the quality of life (QOL) due to definitional changes in the concept of health and …

Background Metabolic acidosis, a complication of chronic kidney disease, causes protein
catabolism and bone demineralisation and is associated with adverse kidney outcomes and …

Background Patients with advanced chronic kidney disease lose the capacity to fully excrete
endogenous acid, resulting in chronic metabolic acidosis that increases the risk of disease …

Objective Conflicting findings and knowledge gaps exist regarding links between anemia,
physical activity, health-related quality of life (HRQOL), chronic kidney disease (CKD) …

Erythropoietin (EPO) is the main regulator of red blood cell production. Since the 1990s,
EPO has been used for the treatment of anemia associated with end-stage renal failure and …